The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 24, 2019

Filed:

Jan. 11, 2017
Applicant:

Xuanwu Hospital of Capital Medical University, Beijing, CN;

Inventors:

Lin Li, Beijing, CN;

Hongshun Gu, Beijing, CN;

Lan Zhang, Beijing, CN;

Xi Chen, Beijing, CN;

Linlin Yin, Beijing, CN;

Ruyi Zhang, Beijing, CN;

Cuicui Yang, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 405/12 (2006.01); C07D 311/32 (2006.01); C07D 413/04 (2006.01); A61P 25/28 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 25/16 (2006.01); A61K 31/353 (2006.01); A61K 31/454 (2006.01); A61K 31/496 (2006.01); A61P 25/18 (2006.01); C07D 413/14 (2006.01);
U.S. Cl.
CPC ...
C07D 405/12 (2013.01); A61K 31/353 (2013.01); A61K 31/454 (2013.01); A61K 31/496 (2013.01); A61P 25/16 (2018.01); A61P 25/18 (2018.01); A61P 25/22 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); C07D 311/32 (2013.01); C07D 413/04 (2013.01); C07D 413/14 (2013.01);
Abstract

The invention relates to flavanone derivatives, and preparation method and use thereof, particularly relates to a compound of Formula I or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, a preparation method thereof, and use thereof for preventing or treating a mental disorder or a nervous system disease. The compound of the invention exerts significant activity of inhibiting microglial activation and neuroinflammation, can antagonize dopamine D2 receptor, improve the ethological change in multiple animal models for mental disorders, effectively inhibit neuroinflammation and demyelination, and can be used to prevent or treat a mental disorder and a nervous system disease.


Find Patent Forward Citations

Loading…